Sunday, February 22, 2026

Latest

Aurora Cannabis Increases US$400 Million At The Market Offering To US$650 Million

Aurora Cannabis (TSX: ACB) (NYSE: ACB) will be increasing its recently completed US$400 million at-the-market offering as the company previously indicated earlier this week. However, instead of the expected US$350 million increase for the program, the company will only be increasing the figure by US$250 million.

It’s unclear why Aurora elected to not utilize the full amount remaining in its previously filed prospectus to conducted a renewed ATM program. However, documents filed this morning by the company with Sedar indicate that the company has made arrangements with Cowen & Co as well as BMO Capital Markets to increase the original US$400 million program to that of US$650 million.

Aurora entered into the amended agreement with the sales agents, as well as CIBC World Markets and AltaCorp Capital on April 15, for which the sales agents will collect a 2% commission for any shares sold via the at the market distribution.

As per the amended prospectus filed, Aurora intends to utilize the proceeds from the sale of equity for 1) working capital, 2) potential future acquisitions, 3) debt repayments, and 4) capital expenditures.

It is believed that the program has commenced effective today. The result is that investors will now see an additional US$250 million in selling inevitably coming their way over the coming months, causing further dilution.

Aurora Cannabis last traded at $0.67 on the NYSE.


Information for this briefing was found via Sedi and Aurora Cannabis. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

6 Responses

  1. Wait ti they realize CBD oil will help with Corona Virus! I use everyday without THC and I haves had a fever in over a year!! No more aches and pains.This stuff is the future just got to stand up to big Pharma!!

    1. Why would they? Its a large cash incinerating machine?

      Pot Stock investors are learning the hard way all these companies were is a greenhouse and a piece of paper with a government signature.
      I mean ya, sometimes an expensive greenhouse, but that’s it…

Video Articles

1911 Gold: The Power Of A Mine Restart

Is Gold Repeating the 2005 Setup Before The Big Run? | Geordie Mark

DPM Metals Q4 Earnings: Record Cash Flow vs Rising Costs

Recommended

Goliath Resources Sees 13% Grade Boost As Stifel Draws Parallels To Great Bear

First Majestic Q4 2025: Record Revenue, Earnings, Annual Silver Output

Related News

Aurora Cannabis Acquires US Based CBD Company Reliva

In its latest “cost-cutting” move, Aurora Cannabis (TSX: ACB) (NYSE: ACB) announced after today’s closing...

Wednesday, May 20, 2020, 04:35:33 PM

Aurora Cannabis Posts Q4 Revenues Of $72.1 Million, Loss Of $1.9 Billion, Loses $3.3 Billion On The Year

Aurora Cannabis (TSX: ACB) (NYSE: ACB) reported its fourth quarter financial results for the period...

Tuesday, September 22, 2020, 05:07:52 PM

Checking In On Aurora Cannabis’ Operation

On last week’s episode, Aurora Cannabis (TSX: ACB) (NYSE: ACB) was undergoing a shift; changing...

Saturday, February 15, 2020, 12:19:39 PM

Aurora Cannabis Sells Stake In Cann Group At Estimated 58.7% Loss

Aurora Cannabis (TSX: ACB) (NYSE: ACB) has taken a loss on yet another investment, with...

Monday, October 12, 2020, 12:32:32 PM

Aurora Cannabis: Canaccord Anticipates Q2 Revenues Of $69.5 Million

On Thursday, February 11th, Aurora Cannabis (TSX: ACB) (NYSE: ACB) is scheduled to release their...

Tuesday, February 9, 2021, 04:01:00 PM